In a report released today, Swayampakula Ramakanth from H.C. Wainwright downgraded AVEO Pharma ( AVEO - Research Report ) to a Hold, with a price target of $15.00. The companys shares opened today at $14.73. Ramakanth covers the Healthcare sector, focusing on stocks such as X4 Pharmaceuticals, ImmunoGen, and MiMedx Group. According to TipRanks, Ramakanth has an average return of -13.5% and a 28.94% success rate on recommended stocks. Currently, the analyst consensus on AVEO Pharma is a Strong Buy with an average price target of $15.50. See today's best-performing stocks on TipRanks >> The company has a one-year high of $10.59 and a one-year low of $3.06. Currently, AVEO Pharma has an average volume of 338.6K. TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.